Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug entities : Ocular therapeutix, inc. save search
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA®
Published: 2024-02-19 (Crawled : 17:00) - biospace.com/
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
| Email alert
Add to watchlist
dextenza drug health sciences application therapeutics
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis
Published: 2024-02-19 (Crawled : 14:00) - prnewswire.com
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
| Email alert
Add to watchlist
dextenza drug health ocular treatment sciences application therapeutics
Outlook on the Ophthalmic Drug Delivery System Global Market to 2031 - Emerging Novel Ocular Drug Delivery Systems are Driving Growth
Published: 2022-08-11 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: -0.89%
H: 2.16%
C: -0.04%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: 0.82%
H: 0.06%
C: -1.23%
WST | $385.73 -1.15% 0.0% 760K
|
Health Technology
|
| O: 0.6%
H: 1.75%
C: -0.92%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: 0.15%
H: 1.36%
C: 0.17%
ATR | $140.01 0.19% 0.0% 430K
|
Process Industries
|
| O: 0.79%
H: 0.59%
C: -0.91%
SLGN | $47.32 0.19% 0.0% 510K
|
Process Industries
|
| O: -0.31%
H: 0.61%
C: -1.05%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: -0.17%
H: 0.3%
C: -5.86%
EYPT | News | $16.47 -6.26% -6.68% 1.1M
|
Health Technology
|
| O: -0.99%
H: 3.37%
C: 0.91%
CLSD | News P | $1.33 -2.92% -3.01% 200K
|
Health Technology
|
| O: 0.62%
H: 2.45%
C: -4.91%
drug global system ocular growth market
AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
Published: 2022-04-13 (Crawled : 03:00) - prnewswire.com
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 1.21%
H: 5.01%
C: 3.58%
treatment drug dextenza ocular approval therapeutics
Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg for Intracanalicular Use for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Published: 2021-10-11 (Crawled : 19:00) - biospace.com/
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 0.41%
H: 24.11%
C: 14.91%
new drug treatment fda ocular fda approval drug approval
Hydrogel-based Drug Delivery System Market size worth $ 10.29 Billion, Globally, by 2028 at 7.20% CAGR: Verified Market Research®
Published: 2021-10-06 (Crawled : 14:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.05%
C: 0.03%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: -0.41%
H: 2.37%
C: 2.06%
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: -2.87%
drug research drug delivery liver
Global $10+ Billion Hydrogel-based Drug Delivery System Markets to 2028: Natural, Synthetic, Hybrid, Subcutaneous, Ocular, Oral Cavity, Topical
Published: 2021-08-11 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.85%
C: 0.79%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 0.05%
H: 0.5%
C: -0.91%
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: 0.77%
H: 7.16%
C: 5.88%
ocular drug drug delivery liver
Hydrogel-based Drug Delivery System Market Size Worth $10.6 Billion By 2028: Grand View Research, Inc.
Published: 2021-07-21 (Crawled : 10:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.5%
H: 0.23%
C: 0.11%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 0.81%
H: 2.09%
C: 1.77%
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: 1.67%
H: 18.07%
C: 10.8%
drug research drug delivery liver
Future Market Insights' 250 Pages Ocular Drug Delivery System Market Study Identifies Demand for Targeted Techniques for Ophthalmic Disease Treatment, a Chief Growth Driver
Published: 2021-07-01 (Crawled : 14:15) - prnewswire.com
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: -0.07%
H: 1.83%
C: 1.2%
disease treatment ocular drug growth drug delivery liver
Ocular Therapeutix™ Announces Submission to the FDA of a Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Published: 2020-12-22 (Crawled : 17:00) - biospace.com/
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 2.59%
H: 4.27%
C: 2.61%
ocular fda drug submission new drug treatment
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.